Graybug to Present Preclinical Data for GB-401 in Primary Open-Angle Glaucoma at the 2022 ARVO Annual Meeting

3 years ago

BALTIMORE, April 27, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative…

Kraig Biocraft Laboratories Kicks Off Q2 Recombinant Spider Silk Production as Lab Increases Testing Throughput Nearly Ten Fold

3 years ago

ANN ARBOR, Mich., April 27, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the…

Helius Medical Technologies, Inc. Fulfills First U.S. Prescriptions for PoNS®

3 years ago

-- First patients have purchased PoNS devices to initiate PoNS Therapy ---- Nineteen PoNS device prescriptions have been written in…

Carisk Partners’ Alana Letourneau, MD, MBA Named a 2022 Rising Insurance Star Executive Award Winner

3 years ago

MIAMI--(BUSINESS WIRE)--Carisk Partners (Carisk), a specialty risk transfer and care coordination company, is pleased to announce that that Alana Letourneau,…

Sonendo, Inc. To Showcase Newly Launched CleanFlow™ Technology at 2022 AAE Annual Meeting

3 years ago

Located at Booth #1013, Sonendo Will Provide a First Look at the New CleanFlow Procedure Instrument, Offer Hands-on Test Drives…

Azalea Health and Phreesia Partner to Offer an Integrated Intake Experience to Growing Network of Providers

3 years ago

ATLANTA & RALEIGH, N.C.--(BUSINESS WIRE)--Azalea Health, a leading provider of cloud-based patient management and health IT solutions, and Phreesia, a…

XVIVO Submits an IDE Application to US FDA for Its Innovative Heart Technology – a Significant Milestone

3 years ago

GOTHENBURG, SE / ACCESSWIRE / April 27, 2022 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)XVIVO proudly announces the filing of an Investigational…

Spago Nanomedical Interim Report January-March 2022

3 years ago

LUND, SE / ACCESSWIRE / April 27, 2022 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F)Several important milestones in the first quarterJANUARI - MARCH…

Spexis Annual General Meeting 2022

3 years ago

Ad hoc announcement pursuant to Art. 53 LRALLSCHWIL, SWITZERLAND / ACCESSWIRE / April 27, 2022 / Spexis AG (SIX:SPEX) today…

Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering PKU GOLIKE(R)

3 years ago

Notice of Allowance of Patent Application for Modified Release Orally Administered Amino Acid Formulations, Strengthens Proprietary Position in U.S. until…